These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29633048)

  • 21. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod.
    Kragholm K; Newby LK; Melloni C
    Drug Des Devel Ther; 2015; 9():4279-86. PubMed ID: 26273189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory therapies for cardiovascular disease.
    Ridker PM; Lüscher TF
    Eur Heart J; 2014 Jul; 35(27):1782-91. PubMed ID: 24864079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?
    Whayne TF
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):1-10. PubMed ID: 32356107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
    Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety in clinical trials in cardiovascular disease.
    Cohn JN
    J Am Coll Cardiol; 2006 Aug; 48(3):430-3. PubMed ID: 16875964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine: an affordable anti-inflammatory agent for atherosclerosis.
    Thompson PL; Nidorf SM
    Curr Opin Lipidol; 2018 Dec; 29(6):467-473. PubMed ID: 30320614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

  • 29. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
    Banach M; Penson PE
    Curr Atheroscler Rep; 2021 May; 23(7):32. PubMed ID: 33970350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new way of targeting to treat coronary artery disease.
    Siu D
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):1-6. PubMed ID: 19829140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine as an anti-inflammatory and cardioprotective agent.
    Gasparyan AY; Ayvazyan L; Yessirkepov M; Kitas GD
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1781-94. PubMed ID: 26239119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Anti-Atherosclerotic Therapies.
    Gluba-Brzózka A; Franczyk B; Rysz-Górzyńska M; Ławiński J; Rysz J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Colchicine in the Prevention of Cerebrovascular Ischemia.
    Tsivgoulis G; Katsanos AH; Giannopoulos G; Panagopoulou V; Jatuzis D; Lemmens R; Deftereos S; Kelly PJ
    Curr Pharm Des; 2018; 24(6):668-674. PubMed ID: 29336246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging anti-inflammatory drugs for atherosclerosis.
    Berman JP; Farkouh ME; Rosenson RS
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):193-205. PubMed ID: 23675745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of methotrexate in patients with uveitis.
    Ali A; Rosenbaum JT
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S145-50. PubMed ID: 21044449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
    Hemkens LG; Ewald H; Gloy VL; Arpagaus A; Olu KK; Nidorf M; Glinz D; Nordmann AJ; Briel M
    Heart; 2016 Apr; 102(8):590-6. PubMed ID: 26830663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combating Inflammation in Cardiovascular Disease.
    Sethwala AM; Goh I; Amerena JV
    Heart Lung Circ; 2021 Feb; 30(2):197-206. PubMed ID: 33039279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
    Bouabdallaoui N; Tardif JC
    Curr Cardiol Rep; 2021 Jul; 23(9):120. PubMed ID: 34269908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.